February 16,2006
Senator Grassley's Statement for the Record regarding FDA's Approval Process
Please see the following two documents attached as related files:
(1) Grassley Statement from the Feb. 16 Congressional Record
(2) Report of the Committee Staff Review of the FDA’s Approval Process for the Vagus Nerve Stimulation Therapy System for Treatment-Resistant Depression
Next Article Previous Article
Recent News
- Working Families Tax Cuts Help More Americans Save for Health Care
- Working Families Tax Cuts Build a Skilled Workforce
- Senate Unanimously Approves Bipartisan Taxpayer Assistance and Service Act
- Working Families Tax Cuts Make Parenthood More Affordable
- Finance Committee Advances HHS, IRS and U.S. Tax Court Nominations